Berecz Roland

1.

Kövér, L., Szőllősi, G. J., Frecska, E., Bugán, A., Berecz, R., Égerházi, A.: The association between early maladaptive schemas and romantic relationship satisfaction.
Front. Psychol. 15, 1-10, (article identifier: 1460723), 2024.

doi DEA Scopus

Journal metrics:

Q2 Psychology (miscellaneous) (2023)

2.

Magyari, F., Virga, I., Simon, Z., Miltényi, Z., Illés, A., Kósa, K., Ivánka, T., Berecz, R., Égerházi, A., Illés, Á.: Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary.
Support. Care Cancer. 30 (6), 5249-5258, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Oncology

3.

Kellermann, M., Berecz, R., Bereczki, D.: Does the severity of depressive symptoms after stroke affect long-term survival? An 18-year follow-up.
PLoS One. 13 (12), 1-11, 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

4.

Cosh, S., Zenter, N., Ay, E. S., Loos, S., Slade, M., De Rosa, C., Luciano, M., Berecz, R., Glaub, T., Munk-Jørgensen, P., Krogsgaard Bording, M., Rössler, W., Kawohl, W., Puschner, B.: Clinical Decision Making and Mental Health Service Use Among Persons With Severe Mental Illness Across Europe.
Psychiatr. Serv. 68 (9), 970-974, 2017.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Psychiatry and Mental Health

5.

Magyari, F., Kósa, K., Berecz, R., Illés, A., Miltényi, Z., Simon, Z., Illés, Á.: Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
Health Qual. Life Outcomes. 15 (1), 1-9, 2017.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Public Health, Environmental and Occupational Health

6.

Morvai, S., Nagy, A. I., Bálint-Szöllősi, A., Móré, E. C., Berecz, R., Frecska, E.: Ketamin alkalmazása súlyos, terápiarezisztens depressziós beteg esetében.
Ideggyógy. Szle. 69 (11-12), 421-425, 2016.

doi DEA WoS Scopus

Journal metrics:

Q4 Neurology

Q4 Neurology (clinical)

7.

Magyari, F., Miltényi, Z., Simon, Z., Kósa, K., Berecz, R., Illés, Á.: Prognostic value of clinical, treatment and socio-demographic results of psychological distress among Hodgkin Lymphoma survivors in Hungary.
Haematologica. 101, 71, 2016.

DEA WoS

8.

Morvai, S., Nagy, A. I., Kovács, A. I., Móré, E. C., Berecz, R., Frecska, E.: Unanswered questions in the transcranial magnetic stimulation treatment of patients with depression.
Ideggyogy. Szle. 69 (1-2), 4-11, 2016.

doi DEA WoS Scopus

Journal metrics:

Q4 Neurology

Q4 Neurology (clinical)

9.

Balogh, N., Égerházi, A., Berecz, R.: Neurocognitive changes in patients with schizophrenia during relapse and early remission.
Eur. J. Psychiat. 29 (3), 199-209, 2015.

DEA

Journal metrics:

Q3 Psychiatry and Mental Health

10.

Balogh, N., Égerházi, A., Berecz, R., Csukly, G.: Investigating the state-like and trait-like characters of social cognition in schizophrenia: A short term follow-up study.
Schizophr. Res. 159, 499-505, 2014.

DEA

Journal metrics:

Q1 Biological Psychiatry

D1 Psychiatry and Mental Health

11.

Égerházi, A., Balla, P., Ritzl, A., Varga, Z., Frecska, E., Berecz, R.: Automated Neuropsychological Test Battery in depression - preliminary data.
Neuropsychopharmacologia Hung. 15 (1), 5-11, 2013.

DEA

Journal metrics:

Q3 Neurology (clinical)

Q3 Neuropsychology and Physiological Psychology

Q4 Neuroscience (miscellaneous)

Q2 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

12.

Égerházi, A., Glaub, T., Balla, P., Berecz, R., Degrell, I.: P300 enyhe kognitív zavarban és demenciában = P300 in mild cognitive impairment and in dementia.
Psychiatr. Hung. 23 (5), 349-357, 2008.

DEA

Journal metrics:

Q4 Medicine (miscellaneous)

Q4 Psychiatry and Mental Health

13.

Égerházi, A., Berecz, R., Bartók, E., Degrell, I.: Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
Prog. Neuropsychopharmacol. Biol. Psychiatry. 31 (3), 746-751, 2007.

DEA

Journal metrics:

Q2 Biological Psychiatry

Q1 Pharmacology

14.

Emri, M., Glaub, T., Berecz, R., Lengyel, Z., Mikecz, P., Repa, I., Bartók, E., Degrell, I., Trón, L.: Brain blood flow changes measured by positron emission tomography during an auditory cognitive task in healthy volunteers and in schizophrenic patients.
Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 30 (3), 516-520, 2006.

doi DEA

Journal metrics:

Q2 Biological Psychiatry

Q1 Pharmacology

15.

Dorado, P., Berecz, R., Penas-Lledo, E., Cáceres, M. E. S., LLerena, A.: Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs.
Curr. Drug Targets. 7 (12), 1671-1680, 2006.

doi DEA

Journal metrics:

Q1 Clinical Biochemistry

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmacology

16.

Bartók, E., Berecz, R., Glaub, T., Degrell, I.: Cognitive functions in prepsychotic patients.
Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 29 (4), 621-625, 2005.

doi DEA

Journal metrics:

Q2 Biological Psychiatry

Q1 Pharmacology

17.

Berecz, R., de la, R. A., Dorado, P., Fernández-Salguero, P., Dahl, M. L., LLerena, A.: Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
Eur. J. Clin. Pharmacol. 59 (1), 45-50, 2003.

doi

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

Q2 Pharmacology (medical)

18.

Emri, M., Bogner, P., Balkay, L., Tóth, Á., Kisely, M., Weisz, J., Ádám, G., Glaub, T., Berecz, R., Repa, I.: [15 O]-butanol PET-vizsgálatok térbeli standardizálása szegmentált, T1-súlyozott MRI-felvételek segítségével.
Orv. Hetil. 143 (21), 1249-1251, 2002.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

19.

Degrell, I., Berecz, R., Glaub, T., Lengyel, Z., Égerházi, A., Szakáll, S., Trón, L.: A pozitronemissziós tomográfia pszichiátriai alkalmazása = Use of positron emission tomography in psychiatry.
Orv. Hetil. 143 (21), 1311-1314, 2002.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

20.

Glaub, T., Berecz, R., Lengyel, Z., Emri, M., Márián, T., Bartók, E., Trón, L., Degrell, I.: Auditoros eseményhez kötött potenciál és PET: lehetőseg a kognició folyamatának komplex megközelitésére.
Orv. Hetil. 143 (21), 1322-1324, 2002.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)

21.

Berecz, R., LLerena, A., Rubia, A. d. l., Gómez, J., Kellermann, M., Dorado, P., Degrell, I.: Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients.
Pharmacopsychiatry. 35 (6), 231-234, 2002.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous)

Q1 Pharmacology (medical)

Q1 Psychiatry and Mental Health

22.

Berecz, R., Glaub, T., Kellermann, M., Rubia, A. d. l., LLerena, A., Degrell, I.: Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
Pharmacopsychiatry. 33 (1), 42-44, 2000.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous)

D1 Pharmacology (medical)

Q1 Psychiatry and Mental Health

23.

Nagy, E., Berecz, R., Kellermann, M., Degrell, I., Nagy, E. T., Dinya, Z.: The measurement of haloperidol and reduced haloperidol in plasma of psychiatric patients and their relationship to the administered.
Advances in chromatography and electrophoresis 1, 151-159, 1998.

24.

Berecz, R., Nagy, E., Kellermann, M., Degrell, I.: The measurement of the plasma levels of risperidone and its metabolite 9-hydroxyrisperidone in psychiatric patients.
Adv. Chrom. Electrop. 1, 19-23, 1998.

Publication list